Latent Labs

Latent Labs is an AI research lab focused on making biology programmable. The company builds generative models that capture the fundamental principles of molecular biology, enabling the design of new proteins, antibodies, and enzymes from scratch. Rather than just predicting existing structures, these models create novel molecules with specific functions — a shift from analysis to creation. Their suite of models includes Latent-X for atom-level protein binder design, Latent-X2 for drug-like antibodies with low immunogenicity, and Latent-Y, a lab-validated agent that helps researchers design and test drug candidates. The team, which includes co-developers of DeepMind's Nobel Prize-winning AlphaFold, operates from London and San Francisco. Partners use Latent Labs' technology to generate antibodies with improved safety profiles, optimize enzymes for industrial processes, and push the boundaries of genetic engineering. Researchers can apply for early access to the platform, which offers free daily usage and on-demand credits for larger campaigns. The company is backed by Radical Ventures, Sofinnova Partners, and several prominent angel investors including Google's Jeff Dean and Anthropic's Dario Amodei. For biotech companies, drug developers, and academic researchers, Latent Labs provides a way to accelerate the design of biologic molecules that would otherwise take months or years of trial and error — turning complex molecular engineering into a faster, more predictable process.